These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7439262

  • 1. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
    Trnavská Z, Trnavský K.
    Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262
    [Abstract] [Full Text] [Related]

  • 2. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I, Bannwarth B, Monot C, Lapicque F, Netter P, Gaucher A, Royer RJ.
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [Abstract] [Full Text] [Related]

  • 3. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
    Trnavská Z, Trnavský K, Zlnay D.
    Eur J Clin Pharmacol; 1984 Jan; 26(4):457-61. PubMed ID: 6734706
    [Abstract] [Full Text] [Related]

  • 4. Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.
    Gallo JM, Gall EP, Gillespie WR, Albert KS, Perrier D.
    J Clin Pharmacol; 1986 Jan; 26(1):65-70. PubMed ID: 3950052
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Simultaneous pharmacokinetics of benorylate in plasma and synovial fluid of patients with rheumatoid arthritis.
    Aylward M, Maddock J, Rees P, Thomas GM, Wheeldon R, Holly F.
    Scand J Rheumatol Suppl; 1975 Jan; 13():9-12. PubMed ID: 8841
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical pharmacokinetics of the salicylates.
    Needs CJ, Brooks PM.
    Clin Pharmacokinet; 1985 Jan; 10(2):164-77. PubMed ID: 3888490
    [Abstract] [Full Text] [Related]

  • 11. Plasma and synovial fluid gentisate in patients receiving salicylate therapy.
    Cleland LG, Lowthian PJ, Imhoff D, Bochner F, Betts WH, O'Callaghan J.
    J Rheumatol; 1985 Feb; 12(1):136-9. PubMed ID: 3981499
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Protein binding of salicylate in uremic and normal plasma.
    Borgå O, Cederlöf IO, Ringberger VA, Norlin A.
    Clin Pharmacol Ther; 1976 Oct; 20(4):464-75. PubMed ID: 975718
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Time for salicylate diffusion from blood to joint fluid. A study of histopathology of the synovial membrane.
    Soren A.
    Reumatismo; 1977 Oct; 29(1):1-6. PubMed ID: 618099
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transsynovial distribution and protein binding of pirazolac in patients with rheumatoid arthritis.
    Kurowski M, Dunky A, Geddawi M.
    Eur J Clin Pharmacol; 1986 Oct; 31(3):307-11. PubMed ID: 3792428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.